Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Arbutus Biopharma Corp Filed Acc 0001140361-26-038693

Stakes reported in this filing

Reporting person Shares Of the class
Roivant Sciences Ltd. 29,880,079 19.5%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13D_X02/primary_doc.xml…